Gastrointestinal Agents
Felix Hernandez, M.D.
Acid Reducing Agents

Histamine Receptor Blockers:





MOA: Histamine receptor Antagonist
Indications: duodenal/gastric ulcer, hypersecretion of
acid, GERD
Side Effects: Well tolerated. Diarrhea, decreased libido,
impotence. Can be hepatotoxic and renal toxic
Interactions: increases concentration of anticoagulants
Drugs:



Cimetidine (Tagamet)
Ranitidine (Zantac)
Famotidine (Pepcid)
Acid Reducing Agents

Antacids

Aluminum Salts





Calcium Carbonate




MOA: same
Indications: same
Side effects: constipation, hypercalcemia, metabolic alkalosis, milk-alkali
syndrome (rare)
Magnesium Salts




MOA: Neutralize gastric acid thus causing a reduction in mucosal irritation. Relief
of pain precedes healing.
Indications: symptomatic relief of gastric acid irritation
Side Effects: constipation, hypercalcemia, hypophosphatemia
Notes: Magnesium antacids are co administered to prevent constipation
MOA: same
Indications: same
Side Effects: diarrhea, hypermagnesemia  N/V, hyporeflexia, decreased muscle
tone
Sodium Citrate



MOA: same
Indications: Pre-op antacid
Side Effects: Horrible taste but is likely to cause aspiration pneumonitis because it
is nonparticulate
Acid Reducing Agents

Sucralfate (Carafate)




MOA: Sucrose and polyaluminum hydroxide
polymerize at low pH to form a protective
coating
Indications: Prophylaxis and treatment of
duodenal ulcers
Side Effects: Constipation
Interferes with the absorption of fluroquinolone
AB
Proton Pump Inhibitors





Drugs: Omeprazole (Prilosec), Lansoprazole
(Prevacid), Esomeprazole (Nexium), Pantoprazole
(Protonix)
MOA: inhibits hydrogen/potassium ATPase (Proton
pump) of the parietal cells thus reducing acid
secretion.
Indications: reflux esophagitis, duodenal ulcers,
hypersecretory states
Side Effects: Constipation (few side effects)
Omeprazole interacts with warfarin, phenytoin and
diazepam
Dysmotility Agent

Metoclopramide (Reglan)




MOA: increases rate of gastric emptying by an
unknown mechanism
Indications: reflux esophagitis, gastroparesis,
pre-op gastric emptying
Side Effects: diarrhea, constipation, can cause
extra-pyramidal side effects due to dopamine
antagonism (elderly and children)
Increases the toxicity of antipsychotics
Mucosal Protectant

Misoprostol





MOA: increases bicarbonate and mucin release in
the GI tract and reduces acid secretion
Indications: prevention of ulcers caused by
aspirin and other NSAIDS
Side Effects: Abortion (uterine contraction),
diarrhea, abdominal pain, flatulence
Contraindications: PREGNANCY!!!!
Is a prostaglandin analog
Antidiarrheal Agents

Opiates

Diphenoxylate and Atropine (Lomotil)






MOA: diphenoxylate is an agonist at opiate receptors in the GI
tract and atropine blocks muscarinic receptors. Both of these
actions inhibit peristalsis
Indications: Diarrhea
Side Effects: few such as constipation, abdominal/bowel
distention
Contraindications: Parasitic or bacterial infections, obstructive
jaundice
Increased risk of paralytic ileus with antimuscarinics
Loperamide (Imodium)


No drug interactions
Treat OD with Naloxone
Antidiarrheal Agents

Absorbents

Bismuth Subsalicylate (Pepto-Bismol)






MOA: absorbs toxins produced by bacteria and other GI irritants
Indications: Diarrhea, prophylaxis for traveler’s diarrhea
Side Effects: Impaction
Contraindications: Aspirin sensitivity
Potentiates oral anticoagulants
Kaolin/Pectin (Kaopectate)




MOA: adsorbent and protection that is of questionable efficacy
Indications: diarrhea
Side effects: may increase potassium loss or interfere with
absorption of drugs and nutrients
Contraindications: obstructive bowel lesions
Antidiarrheal Agents

Cholestyramine (Questran)




MOA: absorbs bile salts (they cause diarrhea)
and C. difficile toxin
Indications: Diarrhea caused by C. difficile or bile
acids
Side Effects: constipation
Mainly used for lipid disorders
Inflammatory Bowel Agents

Mesalamine and Sulfasalazine



MOA: anti inflammatory
Indications: inflammatory bowel syndrome, UC
or Crohn’s
Will cover more of this drug in a later chapter
Bulk Forming Agents

Psyllium (Metamucil)



MOA: nondigested plant cell wall absorbs water
into feces thus softening the stool
Indications: constipation, hard stools
Side Effects: flatulence, impaction if the bolus is
obstructed
Stimulant Laxatives

Bisacodyl (Dulcolax)


MOA: increases water and electrolytes in feces
and increases intestinal motility
Side Effects: continuous use may cause diarrhea
Milk of Magnesia

Milk of Magnesia (saline solutions)

MOA: magnesium or sodium salts are poorly
absorbed and thus draw water into the lumen.


High dose rids bowel of parasites and empties bowel
preoperatively
Side Effects: precipitation of cardiac, renal,
convulsive disorders or hypocalcaemia
Castor Oil


MOA: metabolized in the intestine to
ricinoleate. It is a surfactant which decreases
water and electrolyte absorption and
increases motility
Side Effects: cramps. Chronic use must be
avoided due the risk of dehydration,
electrolyte imbalance and nerve damage
Polyethylene Glycol (MiraLax)


MOA: hyperosmolarity draws water into the
colon
Side Effects: cramps, N, bloating
Lactulose (Chronulac)


MOA: Hyperosmolarity draws water into the
colon. Gets metabolized in the intestine to
lactate which acts as a laxative osmotically
and by lowering the pH
Side Effects: cramps, flatulence, N/V
Mineral Oil


MOA: Lubricates feces and prevents
absorption of water from feces
Side Effects: anal leakage and irritation,
reduces vitamin absorption

Can develop aspiration pneumonitis with oral
administration
Docusate (Colace)



MOA: improves penetration of water and fat
into feces
Side Effects: diarrhea, abdominal cramps.
It increases the absorption of mineral oil so
do not use together with mineral oil
Obesity Management

Orlistat (Xenical)




MOA: reversible lipase inhibitor therefore it
inhibits the absorption of fats from the intestine
Should be accompanied by a balanced reduced
calorie diet
Multivitamin supplements are needed because
vitamin absorption is decreased by the drug
Patient will have fatty/oily stool